For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Pathology & Laboratory Medicine

You are here


Dr. David P. Hajjar Appointed as Executive Vice Chair of Pathology and Laboratory Medicine

David P. Hajjar, Ph.D.
Executive Vice Chair of Pathology and Laboratory Medicine

It is with great pleasure that I announce the appointment of David P. Hajjar, Ph.D. as Executive Vice Chair of Pathology and Laboratory Medicine, effective immediately. In this capacity, David and I have agreed to work closely on developing strategic and programmatic departmental initiatives, including space development, faculty recruitment and retention, and education. Hence, Dr. Hajjar and I will be closely engaged in further developing a strategic plan for the future direction of the department. He and I have agreed that this will not be done in a vacuum, that we will all work toward this common goal.

David knows our department well. He joined Cornell University Medical College in the Department of Pathology in 1978 as a research fellow, was granted tenure in 1986, and promoted to professor in 1989, one of the youngest to receive tenure in the history of the Medical College. His research focused on the role of herpes virus infection in atherogenesis, and delineating the role of nitric oxide in inflammation and cholesterol trafficking. From 1978 to the present, he has garnered more than $70 million dollars in grant support from extramural sources.  In the 1990’s, David’s administrative acumen and leadership abilities as the founding Director of the Center of Vascular Biology were recognized by the medical center. He served with distinction as Dean of the Cornell University Graduate School of Medical Sciences from 1997 to 2013. From 2000 to 2007, he served as Research Dean and Vice Provost of the Faculty; and from 2003 to 2013, he served as Executive Vice Dean and Executive Vice Provost at the Medical College.  David is now Dean Emeritus and Professor of Biochemistry and Pathology and Senior Advisor to Dean/Provost Augustine Choi. In 2016, he was promoted to University Distinguished Professor by Cornell University.

Weill Cornell Medicine Awarded $9 Million Prestigious Grant for Mantle Cell Lymphoma Research

Selina Chen-Kiang

Selina Chen-Kiang, PhD
Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. The findings may enable investigators to develop superior therapies that are effective, well tolerated and tailored to individual patients with mantle cell lymphoma.

The NCI, part of the National Institutes of Health, offers Program Project Grants to support integrated, multi-project research involving a number of independent investigators who together can improve scientific understanding on a common theme or disease area. This is the first P01 that is solely focused on MCL, which will seek to capitalize on the institution’s strengths in basic and translational research for blood malignancies.

Dr. Massimo Loda Appointed Chair of the Department of Pathology and Laboratory Medicine

Dr. Massimo Loda, an internationally renowned molecular pathologist, has been appointed chair of the Department of Pathology and Laboratory Medicine at Weill Cornell Medicine and pathologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective Feb. 1.

Dr. Loda will helm the institutions’ pathology enterprise, which offers cutting-edge clinical and laboratory services and engages in high-impact science, with a strong focus on the biology of blood and solid tumor malignancies, including prostate cancer. In his new role and as a member of Weill Cornell Medicine’s Sandra and Edward Meyer Cancer Center, Dr. Loda will enhance the Department of Pathology and Laboratory Medicine’s diagnostic capabilities by introducing new techniques, including those that leverage computational pathology and large datasets to identify patterns and trends in disease. He will also seek to recruit outstanding new physicians and scientists to expand the department’s research portfolio and provide exemplary training to the next generation of pathologists. Dr. Loda will succeed Dr. Daniel Knowles, who has served as chair of the department for nearly 25 years.

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192